Population
127 patients at the time of diagnosis
Design
Cross-sectional
Authors
Loading...
Suggests phenotype-specific assessment at diagnosis for cardiac amyloidosis; hypothesis-generating for TTR versus AL monitoring and progression.
At diagnosis, TTR amyloidosis presents with more advanced structural cardiac involvement but less severe heart failure symptoms and biomarker elevation compared to AL amyloidosis.
Cappelli et al. (2015) studied this question.